Astley-Sparke Philip — SEC Form 4 filings
SEC reporting owner CIK 1376491. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-05-20 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 87,864 shares, $595,260 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 32,279 shares @ $8.06 ($260,169) in Replimune Group, Inc., filed 2025-05-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Replimune Group, Inc. (REPL) | Director | 7 | — | 3 legs · 87,864 sh · $595,260 | 5 |
| enGene Therapeutics Inc. (ENGN) | Director | 2 | — | — | 2 |
Form 4 filings — Astley-Sparke Philip
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | Replimune Group, Inc. (REPL) | Gift (G): 50,000 @ $0 | EDGAR |
| 2026-06-17 | 4 | enGene Therapeutics Inc. (ENGN) | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 17,657 @ $5.08 | EDGAR |
| 2026-04-07 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Replimune Group, Inc. (REPL) | Gift (G): 25,000 @ $0 | EDGAR |
| 2025-07-10 | 4 | enGene Holdings Inc. (ENGN) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 32,279 @ $8.06 | EDGAR |
| 2024-08-30 | 4 | Replimune Group, Inc. (REPL) | Gift (G): 50,000 @ $0 | EDGAR |
| 2024-05-20 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 37,928 @ $6.47 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1376491 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →